Ashwini G. Kumar

Helsinki, 00290, Finland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma.

Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma.

Journal: The New England journal of medicine
Published: January 08, 2025

Molecular characterization and SNP identification using genotyping-by-sequencing in high-yielding mutants of proso millet.

Molecular characterization and SNP identification using genotyping-by-sequencing in high-yielding mutants of proso millet.

Journal: Frontiers in plant science
Published: November 25, 2022

FLT3-ITD allelic ratio and HLF expression predict FLT3 inhibitor efficacy in adult AML.

FLT3-ITD allelic ratio and HLF expression predict FLT3 inhibitor efficacy in adult AML.

Journal: Scientific reports
Published: July 14, 2021

Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia.

Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia.

Journal: Cancer discovery
Published: June 08, 2021

Comparison of Structural and Short Variants Detected by Linked-Read and Whole-Exome Sequencing in Multiple Myeloma.

Comparison of Structural and Short Variants Detected by Linked-Read and Whole-Exome Sequencing in Multiple Myeloma.

Journal: Cancers
Published: December 31, 2020

Immunogenomic Landscape of Hematological Malignancies.

Immunogenomic Landscape of Hematological Malignancies.

Journal: Cancer cell
Published: September 15, 2020

KIT pathway upregulation predicts dasatinib efficacy in acute myeloid leukemia.

KIT pathway upregulation predicts dasatinib efficacy in acute myeloid leukemia.

Journal: Leukemia
Published: April 03, 2020

Mutation accumulation in cancer genes relates to nonoptimal outcome in chronic myeloid leukemia.

Mutation accumulation in cancer genes relates to nonoptimal outcome in chronic myeloid leukemia.

Journal: Blood advances
Published: September 09, 2019

Allelic Imbalance of Recurrently Mutated Genes in Acute Myeloid Leukaemia.

Allelic Imbalance of Recurrently Mutated Genes in Acute Myeloid Leukaemia.

Journal: Scientific reports
Published: April 03, 2019

Immunogenomic Landscape of Hematological Malignancies.

Immunogenomic Landscape of Hematological Malignancies.

Journal: Cancer cell
Published: April 01, 2019

Elevated expression of S100A8 and S100A9 correlates with resistance to the BCL-2 inhibitor venetoclax in AML.

Elevated expression of S100A8 and S100A9 correlates with resistance to the BCL-2 inhibitor venetoclax in AML.

Journal: Leukemia
Published: March 08, 2019

Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia.

Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia.

Journal: Haematologica
Published: December 17, 2018
Showing 1-12 of 16

Last Updated: 09/26/2026